Artículos científicos sobre recomendaciones de manejo de enfermedades reumatológicas durante pandemia COVID19

  • EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

 

Abstract: The provisional EULAR recommendations address several aspects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus, and the disease caused by SARS-CoV-2, COVID-19 and are meant for patients with rheumatic and musculoskeletal diseases (RMD) and their caregivers. A task force of 20 members was convened by EULAR that met several times by videoconferencing in April 2020...Descargar artículo.

  • American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 1

 

Due to the rapidly expanding information and evolving evidence related to COVID-19, which may lead to modification of some guidance statements over time, it is anticipated that updated versions of this article will be published, with the version number included in the title. Readers should ensure that they are consulting the most current version. Guidance developed and/or endorsed by the American College of Rheumatology (ACR) is intended to inform particular patterns of practice and not to dictate the care of a particular patient...Descargar artículo.

  • COVID19 Clinical Guidance for Pediatric Patients with Rheumatic Disease

 

The purpose of this document is to provide clinical guidance to 

rheumatology providers who treat children with pediatric rheumatic disease (PRD) (up to age 18) in the context of the COVID‐19 pandemic. These  recommendations have been generated to help guide management and to support shared decision making between providers and individual patients and families...Descargar artículo.

  • COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders

 

The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or the people using their service. It is not mandatory to apply the recommendations, and the guideline does not override the responsibility to make decisions appropriate to the circumstances of the individual, in consultation with them and their families and carers or guardian...Descargar artículo.

  • COVID-19 Clinical Guidance for Adult Patients with Rheumatic Diseases

The purpose of this document is to provide guidance to rheumatology providers on the management of adult rheumatic disease patients in the context of the COVID-19 pandemic. These statements are not intended to replace clinical judgment. Modifications made to treatment plans, particularly in complex rheumatic disease patients, are highly disease-, patient-, geography-, and time-specific and, therefore, must be individualized as part of a shared decision-making process. This guidance is provided as part of a ‘living document,’ recognizing rapidly evolving evidence and the anticipated need for frequent updates as such evidence becomes available....Descargar artículo.

  • American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2

 

Due to the rapidly expanding information and evolving evidence related to COVID-19, which may lead to modification of some guidance statements over time, it is anticipated that updated versions of this article will be published, with the version number included in the title. Readers should ensure that they are consulting the most current version. Guidance developed and/or endorsed by the American College of Rheumatology (ACR) is intended to inform particular patterns of practice and not to dictate the care of a particular patient...Descargar artículo.

  • Atualização das recomendações para os profissionais de saúde e pacientes com doenças inflamatórias imunomediadas: reumatológicas, dermatológicas e gastrointestinais, frente à infecção pelo sars-cov-2 (18/03/2020)

 

Diante da preocupação com o anúncio da pandemia de infecção pelo SARS-Cov-2 (novo Coronavírus 2019) pela Organização Mundial de Saúde (OMS), que causa a doença conhecida como COVID-19, e da declaração de Estado de contenção pelo Ministério da Saúde (MS) do Brasil e Organização Pan Americana de Saúde (Opas), e frente ao reconhecimento do início da transmissão comunitária no país, vimos aqui ratificar e prestar novos esclarecimentos e atualizações acerca do tema...Descargar artículo.